Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 893

1.

The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.

Fesslova V, Vignati G, Brucato A, De Sanctis M, Butera G, Pisoni MP, Chiappa E, Acaia B, Meroni PL.

Cardiol Young. 2009 Jun;19(3):282-90. doi: 10.1017/S1047951109004053. Epub 2009 Apr 22.

PMID:
19383179
2.

Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome.

Breur JM, Kapusta L, Stoutenbeek P, Visser GH, van den Berg P, Meijboom EJ.

J Matern Fetal Neonatal Med. 2008 Jul;21(7):469-76. doi: 10.1080/14767050802052786.

PMID:
18570127
3.

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.

Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK.

Circulation. 2004 Sep 21;110(12):1542-8. Epub 2004 Sep 7. Review.

5.

Outcome of prenatally diagnosed isolated congenital complete atrioventricular block treated with transplacental betamethasone or ritodrine therapy.

Hayashi T, Kaneko M, Kim KS, Eryu Y, Shindo T, Isoda T, Murashima A, Ito Y, Sago H.

Pediatr Cardiol. 2009 Jan;30(1):35-40. doi: 10.1007/s00246-008-9273-5. Epub 2008 Jul 26.

PMID:
18661167
6.

Spectrum and outcome of atrioventricular septal defect in fetal life.

Fesslova V, Villa L, Nava S, Boschetto C, Redaelli C, Mannarino S.

Cardiol Young. 2002 Jan;12(1):18-26.

PMID:
11922436
7.

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.

Mevorach D, Elchalal U, Rein AJ.

Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Review.

PMID:
19584727
8.

Outcome of isolated congenital complete heart block diagnosed in utero.

Groves AM, Allan LD, Rosenthal E.

Heart. 1996 Feb;75(2):190-4.

9.

[Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].

Zemlin M, Bauer K, Dörner T, Altinöz H, Versmold H.

Z Geburtshilfe Neonatol. 2002 Jan-Feb;206(1):22-5. German.

PMID:
11887252
10.

Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block.

Anandakumar C, Biswas A, Chew SS, Chia D, Wong YC, Ratnam SS.

Obstet Gynecol. 1996 May;87(5 Pt 2):835-7.

PMID:
8677107
11.

Successful management of fetal hydrops due to congenitally complete atrioventricular block.

Sivarajah J, Huggon IC, Rosenthal E.

Cardiol Young. 2003 Aug;13(4):380-3.

PMID:
14694963
12.

Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.

Eliasson H, Sonesson SE, Sharland G, Granath F, Simpson JM, Carvalho JS, Jicinska H, Tomek V, Dangel J, Zielinsky P, Respondek-Liberska M, Freund MW, Mellander M, Bartrons J, Gardiner HM; Fetal Working Group of the European Association of Pediatric Cardiology.

Circulation. 2011 Nov 1;124(18):1919-26. doi: 10.1161/CIRCULATIONAHA.111.041970. Epub 2011 Oct 10.

13.

[Complete congenital atrioventricular block. Prenatal diagnosis and perinatal management].

Comas C, Mortera C, Figueras J, Guerola M, Mulet J, Cararach V, Devesa R, Muñoz A, Torrents M, Carrera JM.

Rev Esp Cardiol. 1997 Jul;50(7):498-506. Spanish.

14.

Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.

Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, Hamilton RM, Hornberger LK.

Circulation. 2002 Feb 19;105(7):843-8.

15.

Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience.

Maeno Y, Himeno W, Saito A, Hiraishi S, Hirose O, Ikuma M, Inamura N, Kawataki M, Mizukami A, Ota M, Shiraishi H, Satomi G, Kato H.

Heart. 2005 Aug;91(8):1075-9.

16.

Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.

Skog A, Wahren-Herlenius M, Sundström B, Bremme K, Sonesson SE.

Pediatrics. 2008 Apr;121(4):e803-9. doi: 10.1542/peds.2007-1659.

PMID:
18381509
17.

Successful in utero therapy of fetal heart block.

Copel JA, Buyon JP, Kleinman CS.

Am J Obstet Gynecol. 1995 Nov;173(5):1384-90.

PMID:
7503173
18.

[Analysis of pregnancy, labor and neonatal course in babies with prenatally-diagnosed complete atrioventricular heart block].

Leszczyńska K, Chojnicki M, Haponiuk I, Preis K, Ciach K, Gierat-Haponiuk K, Łajkowski Z.

Ginekol Pol. 2015 May;86(5):366-71. Polish.

PMID:
26117975
19.

The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.

Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J.

Prenat Diagn. 1995 Dec;15(13):1297-302.

PMID:
8710768
20.

Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival.

Peranteau WH, Wilson RD, Liechty KW, Johnson MP, Bebbington MW, Hedrick HL, Flake AW, Adzick NS.

Fetal Diagn Ther. 2007;22(5):365-71. Epub 2007 Jun 5.

PMID:
17556826

Supplemental Content

Support Center